Contribution of coagulation factor VII R353Q polymorphism to the risk of thrombotic disorders development (venous and arterial): A case-control study

Hanan Azzam; Reham M. El-Farahaty; Nashwa K. Abousamra; Hossam Elwakeel; Sherif Sakr; Ayman Helmy; Eman Khashaba

doi:10.1016/j.ejmhg.2016.11.002

Q2 2017

Contribution of coagulation factor VII R353Q polymorphism to the risk of thrombotic disorders development (venous and arterial): A case-control study

Hanan Azzam · Reham M. El-Farahaty · Nashwa K. Abousamra · Hossam Elwakeel · Sherif Sakr · Ayman Helmy · Eman Khashaba

10.1016/j.ejmhg.2016.11.002 402 المشاهدات 1 الاقتباسات

الاقتباسات

402

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Hanan, A., Reham, M. E., Nashwa, K. A., Hossam, E., Sherif, S., Ayman, H., Eman, K. (2017). Contribution of coagulation factor VII R353Q polymorphism to the risk of thrombotic disorders development (venous and arterial): A case-control study. Egyptian Journal of Medical Human Genetics. https://doi.org/10.1016/j.ejmhg.2016.11.002

Abdulbari Bener; Ramzi R. Mohammad · 2017

استشهاد

576

Prevalence of glucose-6-phosphate dehydrogenase deficiency in India: An updated meta-analysis

Pradeep Kumar; Upendra Yadav; Vandana Rai · 2016

استشهاد

466

Magnesium, zinc and copper estimation in children with attention deficit hyperactivity disorder (ADH…

Farida Elbaz; Sally Zahra; Hussien Hanafy · 2017

استشهاد

545

MTHFR C677T polymorphism and risk of esophageal cancer: An updated meta-analysis